Overview Markets Watchlist

© 2026 IR SuperintelMethodology Contact

Revolution Medicines Inc

CUSIP: 76155X105 | 1 institutional holders

Quarters

Compare Detailed Historical Funds Options Short Interest 13D/13G Peers Targeting Trading Summary Profile